Treatment of Patients with Vocal Fold Atrophy and Comorbid Essential Voice Tremor: Long-Term Injection Augmentation Outcomes After Successful Diagnostic Vocal Fold Injection Augmentation
- PMID: 30503608
- DOI: 10.1016/j.jvoice.2018.11.004
Treatment of Patients with Vocal Fold Atrophy and Comorbid Essential Voice Tremor: Long-Term Injection Augmentation Outcomes After Successful Diagnostic Vocal Fold Injection Augmentation
Abstract
Objective: Vocal fold injection augmentation (VFIA) is employed diagnostically for patients with subtle glottic insufficiency. Its use in patients with both vocal fold atrophy and benign essential voice tremor (EVT) has been reported but not after durable augmentation. This study intends to evaluate the success of durable VFIA using either autologous fat or calcium hydroxylapatite in patients with both vocal fold atrophy and comorbid EVT.
Methods/design: Retrospective review. Subjects included demonstrated subtle glottic insufficiency from true vocal fold atrophy and comorbid EVT with no other vocal fold pathology. Voice Handicap Index (VHI-10), aerodynamic data including subglottic pressure and airflow, and the tremor scoring scale were evaluated before diagnostic VFIA with carboxymethylcellulose and after durable VFIA with calcium hydroxylapatite or autologous fat.
Results: Seven patients met inclusion criteria. Six subjects went on to durable VFIA. Three of six demonstrated meaningful improvement in the VHI-10 score. Subglottic pressure improved significantly in those subjects with meaningful VHI-10 improvement compared to those that did not. The tremor did not resolve completely in any subject, but patient satisfaction and function was improved in four of the six.
Conclusions: VFIA for EVT in the setting of true vocal fold atrophy appears to offer benefit and may be an alternative treatment pathway for EVT patients. More than half of the subjects who underwent durable VFIA after successful diagnostic VFIA reported improvement in their communication despite inconsistent objective outcomes. Subglottic pressure improved significantly in half of the subjects who also reported a substantive improvement in their VHI-10.
Keywords: Benign vocal tremor; Essential tremor; Essential voice tremor; Glottic insufficiency; Injection augmentation; Vocal tremor.
Copyright © 2018. Published by Elsevier Inc.
Similar articles
-
Evaluation of a Shorter Follow-up Time to Capture Benefit of a Trial Vocal Fold Augmentation.J Voice. 2019 Mar;33(2):169-175. doi: 10.1016/j.jvoice.2017.10.017. Epub 2018 Jan 17. J Voice. 2019. PMID: 29373176
-
Comparison of long-term voice outcomes after vocal fold augmentation using autologous fat injection by direct microlaryngoscopy versus office-based calcium hydroxylapatite injection.Eur Arch Otorhinolaryngol. 2017 Aug;274(8):3147-3151. doi: 10.1007/s00405-017-4600-1. Epub 2017 May 6. Eur Arch Otorhinolaryngol. 2017. PMID: 28478500
-
Using Trial Vocal Fold Injection to Select Vocal Fold Scar Patients Who May Benefit From More Durable Augmentation.Ann Otol Rhinol Laryngol. 2018 Feb;127(2):105-112. doi: 10.1177/0003489417746188. Epub 2017 Dec 12. Ann Otol Rhinol Laryngol. 2018. PMID: 29231041
-
[Vocal Changes and Laryngeal Modifications in the Elderly (Presbyphonia and Presbylarynx)].Laryngorhinootologie. 2018 Nov;97(11):772-776. doi: 10.1055/a-0652-6758. Epub 2018 Nov 7. Laryngorhinootologie. 2018. PMID: 30406619 Review. German.
-
Treatment of Essential Vocal Tremor: A Scoping Review of Evidence-Based Therapeutic Modalities.J Voice. 2024 Jul;38(4):922-930. doi: 10.1016/j.jvoice.2021.12.009. Epub 2022 Jan 10. J Voice. 2024. PMID: 35022154
Cited by
-
Augmentation laryngoplasty: Results and decision plan.World J Otorhinolaryngol Head Neck Surg. 2024 Sep 2;11(2):232-240. doi: 10.1002/wjo2.212. eCollection 2025 Jun. World J Otorhinolaryngol Head Neck Surg. 2024. PMID: 40535740 Free PMC article.
-
Laryngeal dystonia and vocal tremor response to botulinum toxin injection.Eur Arch Otorhinolaryngol. 2025 Feb;282(2):919-926. doi: 10.1007/s00405-024-09111-z. Epub 2024 Dec 7. Eur Arch Otorhinolaryngol. 2025. PMID: 39643809 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous